Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative

• Lucinda Strycker Orsini
• Brigitta U. MonzF. Hoffmann-La Roche AG
• C. Daniel MullinsUniversity of Maryland, Baltimore
• David Van BruntAbbVie (United States)
• Gregory W. DanielDuke University
• Hans‐Georg EichlerEuropean Medicines Agency
• Jennifer S. GraffNational Pharmaceutical Council
• John Guerino
• Marc L. Berger
• Nirosha Mahendraratnam LedererDuke University
• Pall F. JonssonNational Institute for Health and Care Excellence
• Sebastian SchneeweißBrigham and Women's Hospital
• Shirley V. WangBrigham and Women's Hospital
• William H. Crown
• Wim GoettschUtrecht University
• Richard J. Willke